课题基金 / 基金详情

Role of Prohibitins and SUMOylation in OA pathogenesis

Role of Prohibitins and SUMOylation in OA pathogenesis
抑制素和 SUMO 化在 OA 发病机制中的作用
批准号：
366658
负责人：
Moreau Alain
金额：
$7.29万
依托单位：
Centre hospitalier universitaire Sainte-Justine (Montral, Qubec)
依托单位国家：
加拿大
项目类别：
Operating Grants
财政年份：
2016
资助国家：
加拿大
项目状态：
已结题
起止时间：
2016-11-01 至 2017-11-01
来源：
https://webapps.cihr-irsc.gc.ca/decisions/p/project_details.html?applId=366658&lang=en
关键词：
Articular Chondrocytes Expression Profiling Knee/Hip Osteoarthritis Osteoblasts Phb1 Phb2 Proteomics Str/Ort Mice Sumoylation Transcription Factor Pitx1

项目摘要

项目成果

Moreau Alain的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Osteoarthritis (OA) is the most common form of joint disease and the major cause of chronic disability in adults. It is commonly assumed that multiple factors, including genetic and developmental, metabolic and traumatic factors can trigger OA. Although O
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Interdisciplinary Canadian Collaborative ME Research Network
Directed Grant: Oral Health Network
  • 批准号：
    367972
  • 项目类别：
    Directed Grant
  • 资助金额：
    $61.92万
  • 财政年份：
    2017
  • 负责人：
    Moreau Alain
  • 依托单位：
    Universit de Montral
Rôle of Prohibitins and SUMOylation in Osteoarthritis Pathogenesis
Canadian Collaborative Team Conference on ME/CFS: "Advancing an International Research Agenda to Address ME/CFS Research Priorities"
海外基金